Trevena Financials

Trevena Stock Summary

Trevena competes with Lipocine, Verastem, and VTv Therapeutics. Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. Trevena operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.

Trevena Key Financial Ratios

Trevena Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Trevena's current stock value. Our valuation model uses many indicators to compare Trevena value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Trevena competition to find correlations between indicators driving Trevena's intrinsic value. More Info.Trevena is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Trevena's earnings, one of the primary drivers of an investment's value.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

If you are still planning to invest in Trevena check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Trevena's history and understand the potential risks before investing.